Coya Therapeutics Announces Publication Demonstrating Regulatory T-Cell Dysfunction and Systemic Inflammation in Frontotemporal Dementia, Supporting Mechanistic Rationale for COYA 302 Immune-Restoring Therapy

AI Briefing

• – Regulatory T-cell dysfunction and systemic inflammation in frontotemporal dementia demonstrated in new research, supporting COYA 302 Immune-Restoring Therapy.
• – Coya Therapeutics publishes study on immune system's role in FTD, a progressive neurological disorder.
• – Publication highlights potential therapeutic target for COYA 302, a biologic intended to enhance Treg function.